Literature DB >> 16035144

The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.

Nicholas J Cooper1, Hannah Keage, Daniel Hermens, Leanne M Williams, David Debrota, C Richard Clark, Evian Gordon.   

Abstract

The effects of methylphenidate (MPH) on 32 healthy human male volunteers (aged 18 to 25 years, mean age=22.26) were examined using a within-subject design. Each participant attended six testing periods, held once per week. Within each testing period, three repeat testing sessions were undertaken: pre-medication, on-medication and two hours post-medication. In these sessions, dose was manipulated (placebo, 5 mg, 15 mg or 45 mg) according a double-blind placebo design. In this report, we focus on behavioral, autonomic arousal (heart rate, skin conductance) and psychophysiological (ERP) data acquired during the working memory task. We found increased autonomic arousal (heart rate, skin conductance and blood pressure) with MPH. A linear reduction in reaction time, omission errors and target P3 latency, and a corresponding increase in background P3 amplitude was observed with increased MPH dose. The relationship between these measures supported an increase in performance and underlying brain function with MPH. To our knowledge, this is the first paper to use behavioral, arousal and electrophysiological measures in an integrative approach to study the effects of MPH on healthy adults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035144     DOI: 10.1142/s0219635205000744

Source DB:  PubMed          Journal:  J Integr Neurosci        ISSN: 0219-6352            Impact factor:   2.117


  17 in total

1.  Effect of methylphenidate on mismatched visual information processing in young healthy volunteers: an event-related potential study.

Authors:  Chunyu Han; Yuping Wang; Mian Shi; Wei Mao; Wei Sun
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.

Authors:  Kathrin Finke; Chris M Dodds; Peter Bublak; Ralf Regenthal; Frank Baumann; Tom Manly; Ulrich Müller
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

3.  The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA.

Authors:  Nick A Antic; Peter Catcheside; Catherine Buchan; Michael Hensley; Matthew T Naughton; Sharn Rowland; Bernadette Williamson; Samantha Windler; R Doug McEvoy
Journal:  Sleep       Date:  2011-01-01       Impact factor: 5.849

4.  Expectation to receive methylphenidate enhances subjective arousal but not cognitive performance.

Authors:  Alison Looby; Mitch Earleywine
Journal:  Exp Clin Psychopharmacol       Date:  2011-08-29       Impact factor: 3.157

5.  Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults.

Authors:  Nirit Agay; Eldad Yechiam; Ziv Carmel; Yechiel Levkovitz
Journal:  Psychopharmacology (Berl)       Date:  2010-04-28       Impact factor: 4.530

6.  Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults.

Authors:  David A MacQueen; Arpi Minassian; Brook L Henry; Mark A Geyer; Jared W Young; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

7.  Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects.

Authors:  Leanna Kalinowski; Carly Connor; Rathini Somanesan; Emily Carias; Kaleigh Richer; Lauren Smith; Connor Martin; Macauley Mackintosh; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  Dev Psychobiol       Date:  2019-08-27       Impact factor: 3.038

Review 8.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

9.  Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls.

Authors:  D Tomasi; N D Volkow; G J Wang; R Wang; F Telang; E C Caparelli; C Wong; M Jayne; J S Fowler
Journal:  Neuroimage       Date:  2010-10-26       Impact factor: 6.556

10.  Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.

Authors:  Veronika Engert; Jens C Pruessner
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.